1. Home
  2. WHR vs AUPH Comparison

WHR vs AUPH Comparison

Compare WHR & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Whirlpool Corporation

WHR

Whirlpool Corporation

N/A

Current Price

$28.73

Market Cap

2.2B

ML Signal

N/A

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

N/A

Current Price

$16.40

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WHR
AUPH
Founded
1911
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.2B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
WHR
AUPH
Price
$28.73
$16.40
Analyst Decision
Hold
Buy
Analyst Count
13
7
Target Price
★ $35.55
$18.29
AVG Volume (30 Days)
★ 4.6M
886.4K
Earning Date
10-26-2026
10-30-2026
Dividend Yield
★ 5.98%
N/A
EPS Growth
★ 196.42
N/A
EPS
N/A
★ 0.76
Revenue
★ $21,253,000,000.00
$283,055,000.00
Revenue This Year
N/A
$16.65
Revenue Next Year
$3.00
$17.73
P/E Ratio
★ N/A
$21.44
Revenue Growth
★ 2.58
N/A
52 Week Low
$25.50
$13.52
52 Week High
$94.82
$19.25

Technical Indicators

Market Signals
Indicator
WHR
AUPH
Relative Strength Index (RSI) 45.30 47.90
Support Level $25.50 $15.67
Resistance Level $33.12 $16.48
Average True Range (ATR) 1.68 0.54
MACD 0.21 -0.08
Stochastic Oscillator 43.31 35.52

Price Performance

Historical Comparison
WHR
AUPH

About WHR Whirlpool Corporation

Whirlpool Corp is a manufacturer and marketer of kitchen and laundry appliances, with its presence in different markets around the world. It offers products like refrigerators, washing machines, cooktops, ovens, freezers, and others, which are marketed through various brands such as KitchenAid, Maytag, Amana, Brastemp, Consul, Whirlpool, Jennair, etc. The company's operating and reportable segments are: Major Domestic Appliances (MDA) North America (its key revenue-generating segment), MDA Europe, MDA Latin America, and Small Domestic Appliances (SDA) Global.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: